AMD Beyond Complement and Serine Protease Pathways
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2007 - March 31, 2010
Grant ID
M2007084
Goals
This study will characterize two new genetic risk factors related to wet and dry AMD
Summary
Age-related macular degeneration (AMD) has a complex etiology and is broadly classified as either dry or wet. The dry form is more common, accounting for approximately 90% of patients, and does not typically result in blindness. About 10% of patients have the wet form, in which central vision will be destroyed. We have identified two major genetic factors predisposing some individuals to the more aggressive wet form of AMD and others to the slowly progressing dry type. Together with the new risk factors we will discover, it will be possible to detect who is at increased risk and allow those affected to take preventive measures.
Related Grants
Macular Degeneration Research
How Aging of the Immune System Affects Age-Related Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Masayuki Hata, MD, PhD
Current Organization
Kyoto University
Macular Degeneration Research
Microglia’s Roles in AMD to Inform Therapies for Vision Loss Prevention
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Nobuhiko Shiraki, PhD
Current Organization
Duke University School of Medicine
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital